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       Hydatid disease is caused by the larva of Echinococcus granulosus parasite. Mebendazole (MBZ) is 
used as an alternative choice for the treatment of the disease. Aspartate aminotransferase (AST) is an 
essential enzyme in amino acid metabolism. The aim of the present study is to evaluate the effect of MBZ on 
AST activity of hydatid cyst parasite in order to detect enzymatic parameter for drug efficiency. In the 
present study, AST activity was estimated in the extracts of untreated parasite (hydatid cyst protoscolices) 
and treated samples by MBZ (100 µg final concentration). Samples’ protein quantity and quality were 
detected by Bradford and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) methods 
respectively. For the purpose of determining the significant difference between the two independent 
samples, t-test was conducted. The values of the assayed AST specific activities of treated and untreated 
parasite samples were measured as 0.18 and 1.53U/ml/mg protein respectively. The difference between AST 
activities mean values of the two groups proved to be significant (P<0.05). SDS-PAGE demonstrated protein 
band of 50 kDa for AST enzyme. Considering the effect of the MBZ drug on AST activity in parasite, it can 
be concluded that this enzyme is useful for improving the drug efficiency. 
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INTRODUCTION 
       Hydatid cyst disease is a general name used to 
equate to infection with the parasite larva in 
humans. Echinococcosis should be limited to 
infection with the adult stage in carnivores [1]. As 
an alternative choice, treatment with mebendazole 
(MBZ) 40-50 mg/kg B.W. daily for several 
months has been shown to be highly effective on 
patients [2]. Enzymes are compulsory for survival, 
feeding migration and metabolism of parasites. 
Aspartate aminotransferase (AST) catalyzes the 
reversible transfer of a α-amino group between 
aspartate and glutamate and therefore is an 
essential enzyme in amino acid metabolism. AST 
and alanine transaminase (ALT) are associated 
with liver parenchyma cells. The difference is that 
ALT is found principally in the liver, with 
clinically insignificant amounts found in the 
kidneys, heart, and skeletal muscle, while AST is 
found in the liver, heart (cardiac muscle), skeletal 
muscle, kidneys, brain, and red blood cells [3]. 
AST is commonly measured clinically as an 
indicator for liver health. It is confirmed that the 
elevation of AST activity during the liver disease 
progression should not be automatically referred 
to as liver disease [4]. In the present study, the 
effect of MBZ on the AST activity of parasite is 
discussed. 
 
MATERIALS AND METHODS 
Parasite somatic extract solution preparation 
     Parasites (10 samples) were obtained from 10 
infected liver tissues with hydatid cysts of sheep 
slaughtered at a local abattoir (Soleimani, 
Tehran,Iran). The parasites were washed 3 times 
and cultured in PBS media, pH 7.2 with 100 µg 
 




final concentration of MBZ (Tolid Darou Co., 
Iran) or without the drug for 4-6 hours in an 
incubator (37°C). After precipitation and 
washing samples, parasites were freeze-
thawed 3 times in liquid nitrogen and water 
bath at 37 °C and sonicated in a 150 W 
ultrasonic disintegrator with10 sec shock and 
10 sec rest on ice until no intact parasite were 
visible microscopically. Then suspensions 
were centrifuged (10000 ×g for 30 min at 
4°C) and supernatants were stored at -20°C 
[5]. 
Protein assay  
    The concentration of protein in the extract 
solutions of parasite were estimated by the 
method of Bradford using bovine serum 
albumin (1mg/ml) as the standard [5]. 
Aspartate aminotransferase activity assay  
    AST activities in samples were assayed 
using the enzyme assay kit (Ref. number 
92002; Pars Azmoon Company). The kit uses 
L-aspartate and 2-oxoglutarate as substrates 
and produces L-glutamate and oxoglutarate 
which finally leas to production of NAD
+
and 
L- malate; the changes in absorbance can be 
measured at 340 nm. To enzyme assay, 100 μl 
of sample was added to each cuvette 
containing 1ml of working solution at 37°C. 
Immediatly, absorbances (Abs) at 1, 2, 3 
minutes were measured at 340 nm with a 
spectrophotometer. After subtracting Abs 
values, mean value was calculated and AST 
activity of the test samples and controls were 
estimated [6]. 
 
SDS-PAGE preparation of samples 
    Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) method with coomassie 
blue staining was used to separate and stain the 
protein components of parasite samples. Samples 
were mixed with sample buffer and run on 12.5% 
acrylamide gels. Molecular weights of differentiated 
bands of sample proteins were determined with 
respect to the protein marker; the ratio factor was 
calculated afterwards [5]. Proteins were identified 
primitively by database protein [7]. 
Statistical analysis results 
     Independent two sample T-test was provided to 
compare the mean values of enzyme activities 
between the treated and untreated samples. Statistical 
comparisons were carried out using statistical 
softwar(http://www.socscistatistic.com)[8]  
Abbreviations 
     Mebendazole (MBZ); Aspartate transaminase 
(ASP); Absorbances (ABS); Sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE); 
Alanine transaminase (ALT); Kilo Dalton (kDa); 
Molecular weight (MW) 
 
RESULTS 
Protein amounts, enzyme activities and statistical 
analysis results 
     The mean values of protein concentrations and 
enzyme activities for treated parasite and untreated 
samples by MBZ are presented in Table 1. Significant 
difference in AST activities of the two groups were 
observed(p<0.05)
 




AST total activity(U/ml) AST specific 
activity(U/ml/mg protein) 
Treated  with MBZ 0.06 0.01 0.18 
Untreated parasite 0.07 0.13 1.53 









SDS-PAGE analysis results 
     Extract samples of parasites were analyzed 
using SDS-PAGE;  the results are shown in Figure 
1. SDS-PAGE shows protein band with 50 kDa for 
AST of samples. Identified proteins are presented  
in Table 2. Protein bands of 75, 58, 42, 20 and 19 
kDa were observed in control group and were not 
observed in the test group. 
 
 
Figure 1 SDS- PAGE investigation of proteins from the extracts of parasite. First column is protein marker. Column 1-3 are 
treated parasite samples by MBZ and column 4-6 are untreated parasite samples. 
Table.2. Recognized protein bands of parasite according to Expasy database  
Recognized proteins MW from Expasy database MW in Gel 
Improtin 5 




DNA repair protein UVH 3 




Phosphatase and tensin 
Activated cdc 42 Kinase 1 











Phosphoenol pyruvate carboxylase 72.271 72.290 
TGR : Thioredoxin glutathione reductase 




Eg MKK 2 
NADH dehydrogenase subunit 5 





AMP activatedprotein kinase 
Phosphoenol pyruvate carboxylase 
α-amylase 












( AST ) Aspartate amino transferase 
















Smad A protein 





14-3-3-protein homolog 2 
Eukaryotic translation factor 6 
Universal stress protein in QAH:OAS 
Proliferating cell nuclear antigen 









Peptidyl- prolylcis-trans isomerase 
Golgi SNAP receptor complex member 2 
Peptidyl- prolylcis-trans isomerase 





















Calcineurine B ( cal B) 
Calsium B like protein 
ZZKDa antigen 5 
ND1 
ND1 
ATPase sub unit 6 














Argenine N-methyl transferase 1 




NADH dehydrogenase sub unit 1 16.262 16.990 
Cytochrome C oxidase sub unit 1 





Cytochrome C oxidase sub unit 1 




Cytochrome C oxidase sub unit 1 
Cytochrome C oxidase sub unit 1 
Cytochrome C oxidase sub unit 1 
Cytochrome C oxidase sub unit 1 
Cytochrome C oxidase sub unit 1 















Cytochrome C oxidase sub unit 1 
Cytochrome C oxidase sub unit 1 
Cytochrome C oxidase sub unit 1 
Cytochrome C oxidase sub unit 1 
Cytochrome C oxidase sub unit 1 












     Hydatidosis is an endemic parasitic disease 
which is known by its pathogen the 
Echinococcus granulosus larval parasite in 
Iran’s human population and other parts of the 
world [9]. Numerous studies on the treatment 
methods of hydatid cyst have been done in the 
last few decades. Before 1961 and the 
discovery of the Benzimidazoles, the only 
treatment was surgery but a lot of patients 
who could not be operated on were victims of 
complications of the disease and even death. 
With discovery of Benzimidazoles, numerous 
studies were carried out on the chemotherapy 
of the Hydatid cyst. The first drug which was 
used was MBZ; yet, another medicine from 
this family named albendazole (ABZ) was 
used for treatment of distributed Hydatid cyst 
[10, 11]. Another medication for hydatid cyst  
is Praziquantel (PZQ) from Isoquinolins 
group. This drug has been mostly used in the 
treatment of adult gastrointestinal worms in 
dogs and canines but in recent years its 
therapeutic effects have been reported on the 
larval stage protosculex; however, it has had 
no significant inhibitory effect on the growth 
of cysts. Therefore, many studies on using 
ABZ alongside PZQ in vitro and animal 
models and human cases have been done 
which had promising results [12, 13]. 
This study aims to determine the effects of 
MBZ on the AST activity in the parasite 
which is important in the evaluation of the 
drug effects on parasite treatment.  
As mentioned before, benzimidazole 
compounds (ABZand MBZ) are the basis for 
chemotherapy of  hydatid cyst. Since 1977 
which marks the introduction of 
Benzimidazole Carbamats, it has been 
proposed not only as the sole treatment 
method in inoperable cases, but as an aid in 
surgery. Since benzimidazoles are slightly 
soluble in water, their absorption in small 
intestine is limited (yet plasma 
concentrations of ABZ is more than MBZ) 
and they have low or even no risk of toxicity 
to the host and they do not enter the food 
chain which is the best advantage of these 
drugs [14]. When ABZ is absorbed in the 
intestine, it would rapidly be metabolized in 
the liver. In human and animals, its main 
metabolite is albendazole sulfoxide which is 
the cause of anti-worm activity of the 
medicine. This substance passes the cyst wall 
and can be detected in cyst fluid.  
Treatment using the ABZ in 84 percent of the 
cases led to disappearance of the cyst and in 
more than 42 percent of the cases led to 
significant size reduction of the cyst [15]. 
According to above and similar pieces of 
evidence,  the important point is the necessity 
of prevention, treatment, control and fighting 
against this disease that requires 
understanding the mechanisms of 
pathogenesis, drug resistance and the 
physiology of parasites [16]. According to 
review studies conducted in local databases, 
no documented research on comparison of the 
effects of the MBZ drug on the AST enzyme 
activity of parasite was found; therefore this 
study is the first in the country.The tests in 
this study indicated that there is a significant 
difference between average AST activity 
level with and without the presence of MBZ 
medicine so that average enzyme activity 
level in the samples with the presence of the 
 




medicine is significantly lower than that of 
the control samples. 
Also there are some differences between the protein 
bands in parasite with and without the presence of 
the medicine so that the following 5 bands (19, 20, 
42, 58, 75 kDa) which were present in control 
samples are not formed in the test samples.  
The similar and different protein bands in the 
parasite which were obtained from samples 
using SDS-PAGE method are very important 
in view of biochemical comparisons. With this 
method, 50 kDa protein bands were identified 
for the AST enzyme in parasitic samples [3].  
The band intensity in test samples was weaker 
compared to controls, which confirms the 
activity reduction of the enzyme in test 
samples. 
 The identification of proteins obtained in the 
gel can be used in future studies. Enzyme 
activity in parasites of animal hydatid cysts 
due to the limited availability of human liver 
tissue can be used as a research model for 
studies of human cyst. Results obtained shows 
that the MBZ causes the decrease of AST 
activity. Decrease in enzyme is also evident in 
electrophoresis, leading to the decrease of 
colors in the bands which are formed in the 
test samples.  The role of enzymes and 
enzyme systems in living organisms are quite 
impressive and clear and worms are associated 
with these enzymes; any deficiency or 
inhibition in them would prevent parasite life. 
Considering the effect of the MBZ on AST 
activity in parasite, it can be concluded that 
this enzyme is useful for treatment efficiency. 
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